Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru



ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print)
2021 / N 3

Частота встречаемости и клиническая картина лекарственно-индуцированных поражений легких у онкогематологических пациентов
В.Р. Янбухтина, И.С. Зюзгин, Т.В. Шнейдер, И.Ю. Николаев, А.А. Зверькова, И.А. Боровичков, Г.Б. Кучма, Е.А. Кулагин, Л.В. Стельмах, А.Г. Смирнова, Ю.Ю. Власова, Е.В. Морозова, Ж.А. Миронова, И.С. Моисеев, В.И. Трофимов

References

1. Malignant neoplasms in Russia in 2020 (morbidity and mortality). Kaprin AD, Starinskiy VV, Shakhzadova AO, editors. Moscow: PA Herzen Moscow State Medical Research Institute, branch of FSBI “NMRC of Radiology” of the Ministry of Health of the Russian Federation; 2021. 252 p. Available from: https://glavonco.ru/cancer_register/%D0%97%D0%B0%D0%B1%D0%BE%D0%BB_2020_%D0%AD%D0%BB%D0%B5%D0%BA%D1%82%D1%80.pdf Accessed 2022 Apr 29 (In Russian).
2. Zhiguleva LYu, Petrova NG, Romanenko NA. Analysis of hemoblastosis morbidity rate of Saint Petersburg population for 1990–2016 period and forecast till 2026. Manager of Health Care 2019;1:24-34 (In Russian).
3. Orlova NV, Ostroumova OD, Shikh EV, Smerdin SV, Rebrova EV, De VA. Lung injury induced by antitumor drugs: diagnosis, features of the clinical course, risk factors, differential diagnosis, treatment, and prevention. Part 1. Tuberculosis and Lung Diseases 2021;99(7):55-62 (In Russian).
4. Orlova NV, Ostroumova OD, Shikh EV, Smerdin SV, Rebrova EV, De VA. Lung injury induced by antitumor drugs: prevalence, certain drugs and their mechanisms of action. Part 2. Tuberculosis and Lung Diseases 2021;99(8):54-60 (In Russian).
5. Lepik KV, Mikhaylova NB, Kondakova EV, Tsvetkova LA, Zalyalov YuR, Borzenkova ES, Moiseyev IS, Baykov VV, Afanasyev BV. Efficacy and safety of nivolumab in the treatment of relapsed/refractory classical Hodgkin’s lymphoma: Pavlov First Saint Petersburg State Medical University experience. Oncohematology 2018;13(4):17-26 (In Russsian).
6. Bukamur H, Katz H, Alsharedi M, Alkrekshi A, Shweihat YR, Munn NJ. Immune checkpoint inhibitor-related pulmonary toxicity: focus on nivolumab. Southern Medical Journal 2020 Nov;113(11):600-5.
7. Chubenko VA. Medical treatment of tumors: what a practical oncologist needs to know. Practical Oncology 2017;18(4):361-9 (In Russian).
8. Medeiros BC, Possick J, Fradley M. Cardiovascular, pulmonary, and metabolic toxicities complicating tyrosine kinase inhibitor therapy in chronic myeloid leukemia: strategies for monitoring, detecting, and managing. Blood Reviews 2018 Jul;32(4):289-99.
9. Gheith O, Cerna M, Halim MA, Nampoory N, Al-Otaibi T, Nair P, Said T, Atteya HA, Katchy K. Sirolimus-induced combined posterior reversible encephalopathy syndrome and lymphocytic pneumonitis in a renal transplant recipient: case report and review of the literature. Experimental and Clinical Transplantation 2017 Feb;15(Suppl 1):170-4.
10. Almeida F, Amorim S, Sarmento A, Santos L. Life-threatening everolimus-associated pneumonitis: a case report and a review of the literature. Transplantation Proceedings 2018 Apr;50(3):933-8.
11. Baig J, Shokouh-Amiri M, Chan J, Chowdhery R, Danthurthy S, Venepalli NK. The spectrum of pulmonary toxicity in pancreatic cancer patients receiving gemcitabine combination chemotherapy. Case Reports in Oncology 2019 Jul;12(2):506-12.
12. Ostroumova OD, Listratov AI, Kochetkov AI, Sychev DA. Drugs associated with drug-induced interstitial lung diseases. Good Clinical Practice 2021;2:39-51 (In Russian).
13. Tvsvgk T, Handa A, Kumar K, Mutreja D, Subramanian S. Chemotherapy-associated pulmonary toxicity – case series from a single center. South Asian Journal of Cancer 2021 Nov;10(4):255-60.
14. Anayev EKh. Drug-induced interstitial lung disease: approaches to diagnostics and treatment. Therapeutic Archive 2020;92(3):84-91 (In Russian).
15. Skeoch S, Weatherley N, Swift AJ, Oldroyd A, Johns C, Hayton C, Giollo A, Wild JM, Waterton JC, Buch M, Linton K, Bruce IN, Leonard C, Bianchi S, Chaudhuri N. Drug-induced interstitial lung disease: a systematic review. Journal of Clinical Medicine 2018 Oct;7(10):356.
16. Raghu G, Remy-Jardin M, Ryerson CJ, Myers JL, Kreuter M, Vasakova M, Bargagli E, Chung JH, Collins BF, Bendstrup E, Chami HA, Chua AT, Corte TJ, Dalphin JC, Danoff SK, Diaz-Mendoza J, Duggal A, Egashira R, Ewing T, Gulati M, Inoue Y, Jenkins AR, Johannson KA, Johkoh T, Tamae-Kakazu M, Kitaichi M, Knight SL, Koschel D, Lederer DJ, Mageto Y, Maier LA, Matiz C, Morell F, Nicholson AG, Patolia S, Pereira CA, Renzoni EA, Salisbury ML, Selman M, Walsh SLF, Wuyts WA, Wilson KC. Diagnosis of hypersensitivity pneumonitis in adults. An official ATS/JRS/ALAT clinical practice guideline. American Journal of Respiratory and Critical Care Medicine 2020 Aug;202(3):e36-69.
17. Haanen J, Carbonnel F, Robert C, Kerr KM, Peters S, Larkin J, Jordan K; ESMO Guidelines Committee. Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2017 Jul;28(Suppl 4):iv119-42.
18. Karnaushkina MA, Averyanov AV, Lesnyak VN. Ground glass opacities on CT of the chest in the practice of the clinician: pathogenesis, significance, differential diagnose. The Russian Archives of Internal Medicine 2018;3(41):165-75 (In Russian).
19. Rahi MS, Jindal V, Pednekar P, Parekh J, Gunasekaran K, Sharma S, Stender M, Jaiyesimi IA. Fungal infections in hematopoietic stem-cell transplant patients: a review of epidemiology, diagnosis, and management. Therapeutic Advances in Infectious Disease 2021 Aug;8:20499361211039050.
20. Koulenti D, Zhang Y, Fragkou PC. Nosocomial pneumonia diagnosis revisited. Current Opinion in Critical Care 2020 Oct;26(5):442-9.
21. Walter JM, Wunderink RG. Severe respiratory viral infections: new evidence and changing paradigms. Infectious Diseases Clinics of North America 2017 Sep;31(3):455-74.
22. Ansell SM. Maintaining efficacy but decreasing toxicity in the treatment of Hodgkin lymphoma. HemaSphere 2017;1(1):e7.
23. Johnson P, Federico M, Kirkwood PA, Fosså A, Berkahn L, Carella A, D’Amore F, Enblad G, Franceschetto A, Fulham MJ, Luminari S, O’Doherty M, Patrick P, Roberts JT, Sidra G, Stevens RL, Smith P, Trotman J, Viney Z, Radford J, Barrington SF. Adapted treatment guided by interim PET-CT scan in advanced Hodgkin’s lymphoma. The New England Journal of Medicine 2016 Jun;374(25):2419-29.
24. Tam CS, Allan JN, Siddiqi T, Kipps TJ, Jacobs RW, Opat S, Barr PM, Tedeschi A, Trentin L, Bannerji R, Jackson SR, Kuss BJ, Moreno C, Szafer-Glusman E, Russell K, Zhou C, Ninomoto JS, Dean JP, Wierda WG, Ghia P. Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort. Blood 2022 Feb 23;blood.2021014488. doi: 10.1182/blood.2021014488. Online ahead of print.
25. Smykova OG, Lepik KV, Mikhaylova NB, Kondakova EV, Borzenkova ES, Lepik EE, Zalyalov YuR, Stelmakh LV, Baykov VV, Moiseyev IS, Kulagin AD, Afanasyev BV. Nivolumab-based immunotherapy in relapsed/refractory B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma. Cellular Therapy and Transplantation 2021;10(1):37-43 (In Russian).
26. Pietra GG. Pathologic mechanisms of drug-induced lung disorders. Journal of Thoracic Imaging 1991 Jan;6(1):1-7.
27. Vasakova M, Selman M, Morell F, Sterclova M, Molina-Molina M, Raghu G. Hypersensitivity pneumonitis: current concepts of pathogenesis and potential targets for treatment. American Journal of Respiratory and Critical Care Medicine 2019 Aug;200(3):301-8.
28. Ando H, Suzuki K, Yanagihara T. Insights into potential pathogenesis and treatment options for immune-checkpoint inhibitor-related pneumonitis. Biomedicines 2021 Oct;9(10):1484.
  

[ Содержание выпуска N 3 | Выпуски журнала | Список журналов ]